Optic Neuritis Treatment Market Growth and Opportunities The optic neuritis treatment industry is entering a phase of rapid evolution marked by innovative therapies and expanding pipeline dynamics. Recent clinical advancements in monoclonal antibodies and small-molecule agents have reshaped market growth strategies and influenced market dynamics. Experts are closely monitoring shifts in market share and industry trends to capitalize on emerging Optic Neuritis Treatment Market opportunities. Market Size and Overview The neurotrophic keratitis market is estimated to be valued at USD 203.1 Mn in 2025 and is expected to reach USD 380.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032. Over 2024–2025, the market report highlighted intensified R&D investments in immunotherapies targeting retinal ganglion cell protection, driving an uptick in market revenue. Secondary data reveal rising patient awareness, broadening the market scope across North America and Europe. Market insights indicate robust business growth fueled by novel drug launches and strategic licensing deals, reinforcing positive industry size projections and the Optic Neuritis Treatment Market forecast. Optic Neuritis Treatment Market- https://www.coherentmi.com/industry-reports/optic-neuritis-treatment-market #CoherentMI, #OpticNeuritisTreatmentMarketTrend, #OpticNeuritisTreatmentMarketSize,